QVC Group, Inc. Series B Common Stock
QVCGB
QVCGB was delisted on the 27th of May, 2025.
6 hedge funds and large institutions have $709K invested in QVC Group, Inc. Series B Common Stock in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
59% more capital invested
Capital invested by funds: $447K → $709K (+$262K)
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$126K |
| 2 |
JP Morgan Chase
New York
|
+$12.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
QVCGB Hedge Fund Activity: Q1 2021 in Review
6 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in QVC Group, Inc. Series B Common Stock (QVCGB) for Q1 2021, worth a combined $709K — up 59% from $447K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new QVCGB positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $126K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $2K sold.
- 6 institutional investors held QVC Group, Inc. Series B Common Stock (QVCGB) as of Q1 2021, up from 5 in Q4 2020.
- Funds reported $709K of QVC Group, Inc. Series B Common Stock stock for Q1 2021, up 59% quarter-over-quarter.
- 2 funds opened new QVC Group, Inc. Series B Common Stock positions in Q1 2021 and 1 closed out, a net change of +1 holder.
- The largest QVC Group, Inc. Series B Common Stock buyer in Q1 2021 was Citadel Advisors, an estimated $126K added.
- The largest QVC Group, Inc. Series B Common Stock seller in Q1 2021 was Tower Research Capital (TRC), an estimated $2K sold.
Based on aggregated 13F filings for Q1 2021.